(RFI) – After looking into Vaxzevria, the AstraZeneca/Oxford vaccine, the European Medicines Agency (EMA) is now investigating the Johnson & Johnson vaccine for a possible link to the occurrence of blood clots. This comes just shortly before its expected rollout on the continent.
EMA’s “Pharmovigilance Risk Assessment Committee (Prac) had “launched a study” intended “to assess information on thromboembolic incidents” involving people who have received the Johnson & Johnson vaccine, according to the statement.
Three of these cases were found in US after local authorities had approved the vaccine.
A fourth one -in an unnamed country- resulted in the death of a person during a test phase.